Caricamento...
Reply to “Tolerogenic insulin peptide therapy precipitates type 1 diabetes”
In this issue of JEM, Bergman et al. (https://doi.org/10.1084/jem.20160471) challenge the data published in our previous JEM paper on the preventive effect of tolerogenic vaccination with a strong agonist insulin mimetope in type 1 diabetes. Here, we provide a response to these data and suggest that...
Salvato in:
| Pubblicato in: | J Exp Med |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
The Rockefeller University Press
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5501570/ https://ncbi.nlm.nih.gov/pubmed/28536240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20170285 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|